Table 2.
Comparison of parameters: Baseline versus last follow-up
| Baseline | Last follow up | P | |
|---|---|---|---|
| BCVA* Mean±SD (range) | 2.3±0.93 (0-3.2) | 1.19±1.08 (0-3.2) | <0.00001 |
| Grade of visual acuity, n (%) | |||
| ≥ 20/40 | 3 (4.2) | 17 (23.9) | <0.00001 |
| 20/50-20/100 | 6 (8.4) | 23 (32.4) | |
| 19/100-5/200 | 3 (4.2) | 2 (2.8) | |
| 4/200-LP | 53 (74.6) | 24 (33.8) | |
| No LP | 2 (2.8) | 4 (5.6) | |
| Undetermined | 4 (5.6) | 1 (1.4) | |
| IOP (mm Hg) Mean±SD (range) | 39.3±10.5 (23-62) | 14.5±8.1 (0-48) | <0.00001 |
| Optic disc cupping Mean±SD (range) | 0.52±0.23 (0.2-0.95) | 0.49±0.22 (0.2-0.95) | 0.44 |
| AGM score Mean±SD (range) | 2.6±0.56 (0-3) | 0.52±0.93 (0-3) | <0.00001 |
BCVA - Best corrected visual acuity in logMAR, IOP - intraocular pressure, AGM - antiglaucoma medication, LP - light perception. *BCVA could be evaluated in 67 and 70 cases at baseline and last follow-up, respectively